Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.209
Peer-review started: February 16, 2021
First decision: March 17, 2021
Revised: March 26, 2021
Accepted: July 22, 2021
Article in press: July 22, 2021
Published online: September 25, 2021
Processing time: 211 Days and 18.8 Hours
Gastric cancer (GC) is a multifactorial disease, and several modifiable risk factors have been reported. This review summarizes and interprets two previous quantitative systematic reviews evaluating the association between human papillomavirus (HPV) infection and GC risk. The results of two systematic reviews evaluating the same hypothesis showed a statistically significant difference in summary odds ratios and their 95% confidence intervals. Thus, it is necessary to conduct a subgroup analysis of Chinese and non-Chinese studies. Additional meta-analyses that control for heterogeneity are required. Reanalysis showed that all the Chinese studies had statistical significance, whereas the non-national studies did not. The funnel plot asymmetry and Egger's test confirmed publication bias in the Chinese studies. In addition, the proportion of HPV-positive cases in Chinese studies was 1.43 times higher than that in non-Chinese studies and 2.81 times lower in controls. Therefore, the deduced evidence is currently insufficient to conclude that HPV infection is associated with GC risk.
Core Tip: Chinese studies showed that human papillomavirus infections increased the risk of gastric cancer; however, non-Chinese studies showed no statistical significance. Therefore, the deduced evidence is currently inadequate to conclude that human papillomavirus infection is associated with gastric cancer risk.